BR112018068941A2 - prevenção de adesão de tecidos biológicos - Google Patents

prevenção de adesão de tecidos biológicos

Info

Publication number
BR112018068941A2
BR112018068941A2 BR112018068941-6A BR112018068941A BR112018068941A2 BR 112018068941 A2 BR112018068941 A2 BR 112018068941A2 BR 112018068941 A BR112018068941 A BR 112018068941A BR 112018068941 A2 BR112018068941 A2 BR 112018068941A2
Authority
BR
Brazil
Prior art keywords
biological tissue
prevention
self
tissue adhesion
amino acids
Prior art date
Application number
BR112018068941-6A
Other languages
English (en)
Inventor
Kobayashi Satoru
Original Assignee
3-D Matrix, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3-D Matrix, Ltd. filed Critical 3-D Matrix, Ltd.
Publication of BR112018068941A2 publication Critical patent/BR112018068941A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system
    • A61B2017/00823—Appendectomy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00893—Material properties pharmaceutically effective

Abstract

métodos e materiais para atenuar a adesão do tecido biológico são aqui descritos. um método para atenuar a adesão a um tecido biológico inclui a administração de uma quantidade eficaz de uma solução de peptídeo de automontagem ao tecido biológico, em que o peptídeo de automontagem tem entre cerca de 7 aminoácidos e 32 aminoácidos de comprimento e a solução de peptídeo de automontagem forma um hidrogel sob condições fisiológicas.
BR112018068941-6A 2016-03-18 2017-03-17 prevenção de adesão de tecidos biológicos BR112018068941A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662310131P 2016-03-18 2016-03-18
US201662310121P 2016-03-18 2016-03-18
US62/310,131 2016-03-18
US62/310,121 2016-03-18
PCT/IB2017/000312 WO2017158420A1 (en) 2016-03-18 2017-03-17 Preventing biological tissue adhesion

Publications (1)

Publication Number Publication Date
BR112018068941A2 true BR112018068941A2 (pt) 2019-04-16

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018068941-6A BR112018068941A2 (pt) 2016-03-18 2017-03-17 prevenção de adesão de tecidos biológicos

Country Status (11)

Country Link
US (3) US20190091376A1 (pt)
EP (1) EP3429653B1 (pt)
JP (1) JP7049557B2 (pt)
KR (1) KR20190022455A (pt)
CN (1) CN109152868A (pt)
AU (2) AU2017232540A1 (pt)
BR (1) BR112018068941A2 (pt)
CA (1) CA3017684A1 (pt)
CL (1) CL2018002646A1 (pt)
MX (1) MX2018011121A (pt)
WO (1) WO2017158420A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7442196B2 (ja) 2018-07-03 2024-03-04 株式会社スリー・ディー・マトリックス イオン性自己組織化ペプチド
KR20220161384A (ko) 2020-03-31 2022-12-06 가부시끼가이샤 쓰리디 매트릭스 조사에 의한 자기 조립 펩티드의 멸균

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1843776A4 (en) * 2004-07-06 2011-05-11 3D Matrix Inc PURIFIED AMPHILIC PEPTIDE COMPOSITIONS AND ITS USE
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
CN101267831B (zh) * 2005-04-25 2013-04-24 麻省理工学院 用于促进止血和其它生理活动的组合物和方法
BRPI0920030B1 (pt) * 2008-10-06 2019-03-26 3-D Matrix, Ltd. Agente de oclusão do tecido, agentes hemostáticos, preventivos e de oclusão ou escleroterapia relacionados, e infusão do tecido mucosal
US20140329914A1 (en) * 2011-09-02 2014-11-06 3-D Matrix Ltd. Amphiphilic Peptides for Thoracic Air Leakage Occlusion
EP2919826A1 (en) * 2012-11-14 2015-09-23 3-D Matrix Ltd. Vascular embolic system
WO2014141160A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd Treatment for bile leakage

Also Published As

Publication number Publication date
AU2017232540A1 (en) 2018-09-27
EP3429653A1 (en) 2019-01-23
US20190091376A1 (en) 2019-03-28
CA3017684A1 (en) 2017-09-21
MX2018011121A (es) 2019-01-31
CL2018002646A1 (es) 2019-07-05
AU2021225225A1 (en) 2021-09-30
US20230241294A1 (en) 2023-08-03
EP3429653B1 (en) 2022-11-09
US20220111126A1 (en) 2022-04-14
JP7049557B2 (ja) 2022-04-07
KR20190022455A (ko) 2019-03-06
WO2017158420A1 (en) 2017-09-21
CN109152868A (zh) 2019-01-04
JP2019508184A (ja) 2019-03-28

Similar Documents

Publication Publication Date Title
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
MD3386484T2 (ro) Compoziții și metode de livrare a unor agenți terapeutici
DOP2017000272A (es) Métodos de diagnóstico para tratamiento con linfocitos t
WO2017163132A3 (en) Use of umbilical cord blood derived exosomes for tissue repair
PE20170140A1 (es) Metodos para tratar el cancer con inhibidores de tigit y agentes contra el cancer
BR112018068838A2 (pt) oclusão de fístula pancreática
EP4104867A3 (en) Compositions and methods for treatment of central nervous system diseases
BR112015006828A8 (pt) composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; uso do composto; e método para modular a atividade de uma proteína ire1
PH12020500321A1 (en) Amino acid compositions for the treatment of liver disease
BR112015022747A2 (pt) materiais de prevenção de obstrução gastrointestinal
PE20200748A1 (es) Composiciones de aminoacidos para el tratamiento de lesion neuronal
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
MX2016016832A (es) Materiales y metodos para llenar cavidades oseas.
EP3501532A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
BR112015028692A8 (pt) agente preventivo ou terapêutico para mastite de animal ruminante
CO2019009000A2 (es) Combinaciones farmacéuticas para tratar cáncer
EA201991015A1 (ru) Модифицированные пептиды
BR112018068941A2 (pt) prevenção de adesão de tecidos biológicos
BR112016023519A2 (pt) inibidor de sinalização de wnt/ß-catenina, composição farmacêutica e método de tratamento e/ou prevenção de uma patologia definida por malformação vascular
ES2421407T3 (es) Agente y composición para la curación de heridas
PE20160847A1 (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
BR112018077219A2 (pt) matriz de peptídeo de automontagem para a prevenção de estenose esofágica após dissecção endoscópica
MX2016016844A (es) Materiales y metodos para rellenado de cavidades oseas dentales.
PE20160848A1 (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
BR112018068939A2 (pt) oclusão de vazamento de fluido cérebro-espinhal

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements